Corporation reported robust financial results for Q4 2024, driven by strong production and strategic initiatives. The company highlighted its record safety performance and progress in integrating its ...
Earnings: -$53 million in Q4 vs. -$105 million in the same period last year. EPS: -$0.08 in Q4 vs. -$0.15 in the same period last year. Excluding items, Dow Inc. reported adjusted earnings of $2 ...
Sanofi (NASDAQ:SNY) reported robust financial results for the fourth quarter of 2024, driven by significant sales growth and a solid increase in earnings per share (EPS). The company's net sales rose ...